Integrated Diagnostics Holdings PLC 2024 AR2
The report details the financial and operational performance of Integrated Diagnostics Holdings (IDH) for the fiscal year 2024. The company achieved a record consolidated revenue of EGP 5,720 million, representing a 39% year-on-year increase, and a net profit of EGP 1.0 billion. Operationally, IDH expanded its footprint by launching its first two branches in Saudi Arabia under the Biolab KSA brand and completed its delisting from the Egyptian Exchange to focus on its London Stock Exchange listing. Additionally, the company published its third Sustainability Report and established its baseline Scope 1 and Scope 2 emissions inventory for its operations in Egypt and Jordan.
Company: Integrated Diagnostics Holdings PLC
Sector: Health Care
Country: Jersey
Year: 2024
Type: AR2
Pages: 95
Integrated Diagnostics Holdings PLC
Annual Report
The report details the financial and operational performance of Integrated Diagnostics Holdings (IDH) for the fiscal year 2024. The company achieved a record consolidated revenue of EGP 5,720 million, representing a 39% year-on-year increase, and a net profit of EGP 1.0 billion. Operationally, IDH expanded its footprint by launching its first two branches in Saudi Arabia under the Biolab KSA brand and completed its delisting from the Egyptian Exchange to focus on its London Stock Exchange listing. Additionally, the company published its third Sustainability Report and established its baseline Scope 1 and Scope 2 emissions inventory for its operations in Egypt and Jordan.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2024
Reporting Period
Jan 1, 2024 - Dec 31, 2024
Fiscal Year
2024
Type
Annual Report with Sustainability Disclosures
Language
English
Pages
File Size
Standards & Assurance
Reporting Standards
Materiality Assessment
ESG Data?Experimental — AI-extracted data, may contain inaccuracies
Women on Board
Women in Management
Net Zero Target
Employees